Argenx Enters Japan With Smooth Approval – How Was It Possible?

Strategy Behind Unusual Move

 
• By Lisa Takagi
gMG drug VYvgart entered Japan market in May 2022
Vyvgart approved in Japan for both ACHR antibody positive and negative patients • Source: Shutterstock

More from Japan

More from Focus On Asia